EP3328425
COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.7.2016EP published:
25.8.2021EP application number:
16750495.0
EPO information:
European Patent Register
Max expiry date:
26.7.2036
Title:
COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMENT OF CANCER
Timeline
Today
27.7.2016EP application
25.8.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
FJAELLSKOG, Marie-LouiseAddress:
Cambridge, Massachusetts 02139, US
Name:
CAMERON, JohnAddress:
Cambridge, Massachusetts 02139, US
Name:
CAO, ZhuAddress:
Cambridge, Massachusetts 02139, US
Name:
CIPOLLETTA, DanielaAddress:
Cambridge, Massachusetts 02139, US
Name:
MACISAAC, KenzieAddress:
Cambridge, Massachusetts 02139, US
Priority
Number:
201562198384 PDate:
29.7.2015Country:
US
Number:
201662352637 PDate:
21.6.2016Country:
US
Classification
Categories:
C07K 16/28, A61P 35/00, C07K 16/24, A61K 39/395